ALS Association – In Vivo Target Validation

Ends on 26 June 2023

In Vivo Target Validation grants enable the evaluation of novel therapeutics for target engagement and disease-modifying potential in ALS.

More details

Webpage: https://www.als.org/research/funding-opportunities/vivo-target-validation-2023